Tom Taulli

Tom Taulli

InvestorPlace Contributor

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Advanced Micro Devices, Inc. (AMD) Stock Is Set for a BIG Breakout

By Tom Taulli, InvestorPlace Contributor

A few years ago, AMD appeared to be on the verge of oblivion, but the company has somehow been able to pull off an impressive turnaround. Although, for the year so far, the stock price has been not so robust. But this could change as the company’s new product line gets traction.

Despite the Hype, Virtual Reality Does Not Matter For Facebook Inc Stock

By Tom Taulli, InvestorPlace Contributor

Facebook's $2 billion Oculus VR deal has not panned out. That doesn't matter much for FB stock, which has many other catalysts

General Electric (GE) Stock Will Not Get a Spark Any Time Soon

By Tom Taulli, InvestorPlace Contributor

GE has lost quite a bit of luster over the years. The big problem has been a lack of a clear-cut vision. It's encouraging that GE has brought in John Flannery as CEO but he faces tremendous challenges.

Roku (ROKU) Stock Is on the Verge of a Short-Term Bounce

By Tom Taulli, InvestorPlace Contributor

A few weeks ago, Roku pulled off a red-hot IPO. But the gains have since faded. But there could be an interesting catalyst: the quiet period.

3 Reasons to Stay Away From Valeant Pharmaceuticals Intl Inc Stock

By Tom Taulli, InvestorPlace Contributor

Valeant has pulled off a nice rally, but with high debt and a weak pipeline, investors in VRX stock should still be wary.

Load More